How Much Did kaiser permanente Raise? Funding & Key Investors

Date August 22, 2025
K

kaiser permanente

COMPANY INFO

The actual company name is Kaiser Permanente. It was founded in 1945 by industrialist Henry J. Kaiser and physician Sidney Garfield. Kaiser Permanente has approximately 220,000 employees as of 2023. Its official websites are kaiserpermanente.org and kp.org. The company operates in the healthcare industry. Kaiser Permanente is an American integrated managed care consortium that provides high-quality, affordable health care services through its network of hospitals, medical offices, and physicians. It serves over 12 million members across multiple states, focusing on preventive care and efficient healthcare delivery. (Wikipedia, Kaiser Permanente Fast Facts)

How Much Did Kaiser Permanente Raise? Funding & Rounds and Investors

Kaiser Permanente is a leading American integrated managed care consortium operating in the healthcare industry. Founded in 1945 by Henry J. Kaiser and Sidney R. Garfield, Kaiser Permanente has grown to employ approximately 235,785 people as of 2023 and serves over 12 million members across multiple states. Known for its commitment to preventive care and efficient healthcare delivery, Kaiser Permanente offers a full spectrum of services through its extensive network of hospitals, medical offices, and physicians.

Kaiser Permanente’s funding history reflects its strategic approach to partnering and investing in innovative healthcare solutions. While its own total fundraising is undisclosed, the organization has participated in, led, or supported at least 26 funding rounds as of June 2024, primarily through its venture arm, Kaiser Permanente Ventures. These investments underscore Kaiser Permanente’s funding strategy focused on advancing healthcare technology, digital health, and care delivery models. Notable funding rounds have targeted companies in plant-based nutrition, surgical training, digital care platforms, and AI-powered clinical solutions. This approach signals a robust commitment to improving both patient outcomes and healthcare operations through strategic investment.

Funding Rounds

Series C - $65 million - 2024-09-04

Series C funding for Vesta Healthcare, a virtual care provider group for home care, to support growth and integration of caregivers into clinical care teams.

Series C - $150 million - 2024-02-23

Series C funding for Abridge to accelerate R&D and expand its generative AI clinical documentation platform.

Series B - $30 million - 2024-02-23

Series B funding for Abridge, a healthcare AI company, to accelerate adoption of generative AI solutions across U.S. healthcare systems.

Series C - $75 million - 2023-06-21

Series C funding to advance DexCare's patient demand and care access platform, expanding healthcare system capacity and managing digital care access.

Series B - $51 million - 2020-11-12

Series B funding to accelerate growth of Kate Farms, a plant-based nutrition company for healthcare, expanding product availability and innovation.

Series B - $16 million - 2020-11-17

Series B funding for Everytable, a mission-driven food company, to accelerate growth and expand access to healthy, affordable food.

Series A - $14 million - 2020-09-21

Series A funding round for Osso VR, a virtual reality surgical training platform, to scale training and improve surgical performance.

Series B - $45 million - 2020

Series B funding round for IntelyCare, focused on solving the nationwide nursing workforce shortage.

Key Investors

LNK Partners

LNK Partners is one of the key investors supporting Kaiser Permanente-backed funding initiatives. As an experienced private equity firm, LNK Partners brings expertise and capital to help scale health and wellness companies through significant investments and strategic guidance.

Kaiser Permanente Ventures

Kaiser Permanente Ventures serves as the venture capital arm of Kaiser Permanente, leading and co-leading several notable funding rounds. The group focuses on investing in innovative healthcare companies to improve member outcomes, healthcare delivery, and system-wide efficiencies.

Goldman Sachs

Goldman Sachs is a global investment bank and active investor, contributing leadership and capital (notably in the Kate Farms Series B round) to catalyze growth in the health innovation space.

ICONIQ Growth

ICONIQ Growth is a leading global investment firm that co-led DexCare's Series C round, bringing deep expertise in scaling digital health technology companies and enhancing the reach of innovative care delivery platforms.

RA Capital Management

RA Capital Management participated as lead investor in Vesta Healthcare's Series C round, providing fuel for expansion and integrating virtual care into home-based care models.

Creadev

Creadev supported Everytable’s Series B round, backing expansion of accessible, healthy food options and supporting health-focused mission-driven businesses.

Endeavour Vision

Endeavour Vision invested in IntelyCare’s Series B round, supporting solutions to the nationwide nursing shortage and advancing workforce innovations in healthcare.

Lightspeed Venture Partners

Lightspeed Venture Partners led the Series C round for Abridge, fueling AI-driven advancements in clinical documentation to transform healthcare communication and efficiency.

Find funding data on any company with Websets!

Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Kaiser Permanente funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.

With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.

Kaiser Permanente: Funding and Investor Insights